Michael Jacobsen
Financieel Directeur/CFO bij OMEROS CORPORATION
Vermogen: 42 840 $ op 30-04-2024
Actieve functies van Michael Jacobsen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OMEROS CORPORATION | Comptroller/Controller/Auditor | 01-10-2013 | - |
| Financieel Directeur/CFO | 01-08-2013 | - | |
| Treasurer | 01-10-2013 | - |
Loopbaan van Michael Jacobsen
Eerdere bekende functies van Michael Jacobsen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 08-09-2011 | - |
| Financieel Directeur/CFO | 09-09-2011 | 15-11-2011 | |
| Corporate Officer/Principal | 08-09-2011 | 08-09-2011 | |
| Bedrijfssecretaris | 07-09-2011 | 22-04-2013 | |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Operationeel Directeur | 01-04-2007 | 01-08-2011 |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Comptroller/Controller/Auditor | - | - |
| Financieel Directeur/CFO | - | - |
Opleiding van Michael Jacobsen
| Idaho State University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Comptroller/Controller/Auditor | 3 |
| Director of Finance/CFO | 3 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| OMEROS CORPORATION | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
- Beurs
- Insiders
- Michael Jacobsen
- Ervaring